Judgment of the General Court (Second Chamber) of 28 June 2019.#Intercept Pharma Ltd and Intercept Pharmaceuticals, Inc. v European Medicines Agency.#Access to documents — Regulation (EC) No 1049/2001 — Documents held by EMA containing information submitted by the applicants in the context of the marketing authorisation for the medicinal product Ocaliva — Decision to grant a third party access to a document — Exception relating to the protection of court proceedings.#Case T-377/18.

Judgment of the General Court (Second Chamber) of 28 June 2019.
Intercept Pharma Ltd and Intercept Pharmaceuticals, Inc. v European Medicines Agency.
Access to documents — Regulation (EC) No 1049/2001 — Documents held by EMA containing information submitted by the applicants in the context of the marketing authorisation for the medicinal product Ocaliva — Decision to grant a third party access to a document — Exception relating to the protection of court proceedings.
Case T-377/18.

Judgment of the General Court (Second Chamber) of 28 June 2019.
Intercept Pharma Ltd and Intercept Pharmaceuticals, Inc. v European Medicines Agency.
Access to documents — Regulation (EC) No 1049/2001 — Documents held by EMA containing information submitted by the applicants in the context of the marketing authorisation for the medicinal product Ocaliva — Decision to grant a third party access to a document — Exception relating to the protection of court proceedings.
Case T-377/18.

ECLI identifier: ECLI:EU:T:2019:456